135 related articles for article (PubMed ID: 24495688)
1. [Quantitative detection of APC/RASSF1A promoter methylation in the plasma of patients with cervical diseases].
Wang H; Pan SY; Pang ZR; Wang F; Xu J; Chen D; Xie EF; Zhang LX; Gao L; Xu YQ; Jin B
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):929-34. PubMed ID: 24495688
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
[TBL] [Abstract][Full Text] [Related]
3. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
Zheng F; Yu H
Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue].
Xu J; Wang HL; Lu GC; Wang ZJ; Lin X; Zhou HW
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):394-7. PubMed ID: 17697601
[TBL] [Abstract][Full Text] [Related]
7. Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.
Neyaz MK; Kumar RS; Hussain S; Naqvi SH; Kohaar I; Thakur N; Kashyap V; Das BC; Husain SA; Bharadwaj M
Biomarkers; 2008 Sep; 13(6):597-606. PubMed ID: 18608185
[TBL] [Abstract][Full Text] [Related]
8. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
10. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
[TBL] [Abstract][Full Text] [Related]
11. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.
Giannopoulou L; Chebouti I; Pavlakis K; Kasimir-Bauer S; Lianidou ES
Oncotarget; 2017 Mar; 8(13):21429-21443. PubMed ID: 28206954
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.
Bhagat R; Chadaga S; Premalata CS; Ramesh G; Ramesh C; Pallavi VR; Krishnamoorthy L
Cell Oncol (Dordr); 2012 Dec; 35(6):473-9. PubMed ID: 23055343
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma.
Pan Z; Li J; Pan X; Chen S; Wang Z; Li F; Qu S; Shao R
Tumori; 2009; 95(1):76-80. PubMed ID: 19366060
[TBL] [Abstract][Full Text] [Related]
14. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
15. Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.
Liu L; Kron KJ; Pethe VV; Demetrashvili N; Nesbitt ME; Trachtenberg J; Ozcelik H; Fleshner NE; Briollais L; van der Kwast TH; Bapat B
Int J Cancer; 2011 Nov; 129(10):2454-62. PubMed ID: 21207416
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
[TBL] [Abstract][Full Text] [Related]
17. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
18. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
[TBL] [Abstract][Full Text] [Related]
19. [Study of quantitative detection of circulating DNA in the plasma of patients with cervical lesion].
Wang H; Pan SY; Xu J; Zhang MJ; Chen D; Xia WY; Lu YC; Geng Y; Jin B
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):501-4. PubMed ID: 22041441
[TBL] [Abstract][Full Text] [Related]
20. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
